Salivary Gland Infection Market Poised to Hit $6.04 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Salivary Gland Infection Market Size Growth Forecast: What to Expect by 2025?
The market pertaining to salivary gland infections has demonstrated robust expansion throughout the recent past, projected to increase from a valuation of $4.12 billion in the year 2024 to $4.45 billion by 2025, reflecting an annual growth rate (CAGR) of 8.1%. This upward trend observed during the historical timeframe is fueled by several factors, including a surge in oral health problems, heightened public awareness regarding disorders of the salivary glands, a greater incidence of both bacterial and viral infections, the ongoing development of healare facilities, an aging demographic, and the increasing acceptance of treatment modalities that require less invasive procedures.

How Will the Salivary Gland Infection Market Size Evolve and Grow by 2029?
Anticipated substantial expansion is projected for the market encompassing salivary gland infections over the ensuing years, escalating to a valuation of $6.04 billion by 2029, underpinned by a compound annual growth rate (CAGR) standing at 7.9%; this upward trajectory during the projection timeframe is fueled by heightened consciousness regarding dental hygiene, greater utilization of less invasive interventions, a rising incidence of long-term ailments, enhancements in medical support systems, and broader availability of expert medical attention for patients. Key developments shaping this market landscape moving forward encompass the increasing preference for non-invasive methods, progress in the methods of sialendoscopy, utilization of sophisticated visualization apparatus, innovation in inert stent materials, the integration of surgical procedures supported by robotics, incorporating specialized antimicrobial treatments, and the deployment of diagnostic instruments powered by artificial intelligence.

View the full report here:
https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

What Drivers Are Propelling the Growth of Salivary Gland Infection Market Forward?
Anticipated growth in the market for salivary gland infections is fueled by the escalating prevalence of oral health concerns, encompassed by ailments like dental caries, periodontal diseases, and sundry other mouth afflictions; poor dental cleanliness, detrimental dietary patterns, and insufficient availability of dental services are contributing factors to this upward trend in oral health challenges, which consequently heightens the susceptibility to salivary gland infections by fostering microbial proliferation and obstructing the flow through salivary ducts; for example, data released in May 2024 by the United Kingdom's National Health Service indicated that during the 2022-23 period, a total of 32.5 million dental procedures were administered, marking a 23.2 percent year-over-year jump, thereby solidifying the connection between worsening oral health and the expansion of the salivary gland infections market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

Which Emerging Trends Are Transforming the Salivary Gland Infection Market in 2025?
Key players within the landscape of salivary gland infection treatments are focusing heavily on forging ahead with technological progress, especially toward less invasive surgical methods, aiming to boost efficacy in treatment results, speed up how quickly patients bounce back, and generally contribute to greater efficiency in health services delivery. Such less invasive techniques rely on making smaller cuts and employing specialized instruments, which results in reduced harm to surrounding tissues and facilitates a quicker return to health. As an illustration of this trend, in March of 2024, Amrita Hospital, an entity situated in India, unveiled the Amrita Centre dedicated to minimally invasive salivary gland procedures, presenting a revolutionary approach to managing salivary ailments via sialendoscopy, thereby reducing operative necessity and safeguarding the gland's natural function; this opening was prominently marked by a two-day instructional seminar featuring performances by seasoned specialists.

What Are the Key Segments in the Salivary Gland Infection Market?
The salivary gland infectionmarket covered in this report is segmented -

1) By Diagnosis: Plain Radiography; Sialography; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Radionuclide Scintigraphy; High-resolution Ultrasonography; Other Diagnoses
2) By Treatment: Medications; Surgery; Aspiration; Home Care; Other Treatments
3) By End User: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other End User

Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands; Sialography With X-ray
2) By Sialography: Conventional Sialography; Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT; Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast; MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy; SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography; Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy; Endoscopy; Salivary Flow Test

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=21281&type=smp

Who Are the Key Players Shaping the Salivary Gland Infection Market's Competitive Landscape?
Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healare Ltd.

What Geographic Markets Are Powering Growth in the Salivary Gland Infection Market?
North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21281

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.